| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 22 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 22 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 22 |
| 3 | BUSULFAN | 20 |
| 4 | TACROLIMUS | 19 |
| 5 | MYCOPHENOLATE MOFETIL | 18 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 18 |
| 7 | TACROLIMUS OINTMENT 0.1% | 18 |
| 8 | FLUDARABINE PHOSPHATE | 15 |
| 9 | THIOTEPA | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOTEPA | 15 | 0.0015 |
| 1 | BUSULFAN | 20 | 0.0013 |
| 2 | LOMUSTINE | 2 | 0.0008 |
| 3 | URSOSIOL | 13 | 0.0007 |
| 4 | URSODIOL | 13 | 0.0006 |
| 5 | FLUDARABINE PHOSPHATE | 15 | 0.0004 |
| 6 | TREOSULFAN | 1 | 0.0004 |
| 7 | TACROLIMUS OINTMENT 0.1% | 18 | 0.0001 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 18 | 0.0001 |
| 9 | MYCOPHENOLATE MOFETIL | 18 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bile Acid [EPC] | 13 | 0.0006 |
| 1 | Alkylating Drug [EPC] | 22 | 0.0001 |
| 2 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 8 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 5 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Janus Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |